Product correctly added to cart.

discount label
1(S),9(R)-(-)-Bicuculline methbromide
View 3D

Biosynth logo

1(S),9(R)-(-)-Bicuculline methbromide

CAS: 66016-70-4

Ref. 3D-RCA01670

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 23 Jul 2024

Product Information

Name:
1(S),9(R)-(-)-Bicuculline methbromide
Description:

1(S),9(R)-(-)-Bicuculline methbromide is a potent inhibitor of protein kinases that has been shown to induce apoptosis in cancer cells. It is derived from the urine of Chinese strain rats and inhibits the activity of D-xylose kinase, which is involved in the metabolism of xylose. 1(S),9(R)-(-)-Bicuculline methbromide has been studied extensively for its anti-cancer properties and has shown promising results in tumor cell lines. It induces apoptosis in human cancer cells by inhibiting the activity of specific kinases that are essential for cell survival. This compound may be a potential candidate for cancer therapy due to its ability to selectively target cancer cells while sparing normal cells.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
462.3 g/mol
Formula:
C21H20BrNO6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-RCA01670 1(S),9(R)-(-)-Bicuculline methbromide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".